Susquehanna Fundamental Investments, LLC Outlook Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.22 - $2.03 $37,389 - $62,213	-30,647 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.23 $102,175 - $179,410	-80,453 Reduced 72.41%	30,647 $42,000
Q3 2021 Nov 15, 2021	BUY	$2.12 - $2.76 $235,532 - $306,636	111,100 New	111,100 $241,000

31.5K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $326M
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.